
Latin America Gene Expression Market Report and Forecast 2024-2032
Description
Latin America Gene Expression Market Report and Forecast 2024-2032
Latin America Gene Expression Market Report and Forecast 2024-2032
Latin America Gene Expression Market Size
The global gene expression market was valued at USD 13.3 billion in 2023, with Latin America holding a significant market share. The market is driven by the growing emphasis on genomics research. It is expected to grow at a CAGR of 8.50% during the forecast period of 2024-2032, with the values likely to attain USD 32.4 billion by 2032.
Latin America Gene Expression Market Outlook
- In December 2023 , a cross-sectional survey published in the Lancet reported that respondents in Uruguay had the highest levels of self-reported chronic diseases, accounting for 43.2% of the cases. The rising burden of chronic diseases is expected to drive the market demand in the region.
- One of the major Latin America gene expression market trends is the increased strategic partnerships among the key market players to improve access to advanced genomic technologies. In May 2023, Pfizer, and Thermo Fisher Scientific Inc., entered into a collaboration agreement to boost local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in over 30 countries including Latin America.
- In April 2022, Illumina Inc ., announced the launch of a new Solution Center in Brazil, to address the increasing demand for clinical genomics. Such rapid expansion of genomic testing and gene expression analysis capabilities is anticipated to elevate the market value.
The market offers products and services used to study and analyze gene expression including devices for extracting genetic material, amplifying DNA or RNA, and analyzing gene expression patterns. The rising technological advancements leading to enhanced speed, accuracy, and affordability of gene expression analysis coupled with the growing demand for personalized treatment approaches are expected to drive the Latin America gene expression market growth.
Latin America is experiencing a high burden of chronic diseases such as cancer, diabetes, and cardiovascular diseases. In December 2023 , a cross-sectional survey of 4 Latin American countries (Colombia, Mexico, Peru, and Uruguay) published in the Lancet reported that respondents in Uruguay had the highest levels of self-reported chronic diseases, accounting for 43.2% of the cases as compared with approximately 25% in the three other countries. Since gene expression studies are integral for understanding these diseases and developing advanced diagnostic and therapeutic strategies, the Latin America gene expression market demand is expected to witness a surge.
One of the major market trends is the increased strategic partnerships among the key market players to improve access to advanced genomic technologies and impact patient outcomes. For instance, in May 2023, Pfizer and Thermo Fisher Scientific Inc., entered into a collaboration agreement to boost local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in over 30 countries including Latin America. This rising availability and adoption of next-generation sequencing technologies are likely to augment the demand for gene expression analysis tools and technologies, thereby propelling market growth.
The Latin America gene expression market share is also influenced by the growing emphasis on genomics research supported by substantial investments from both the public and private sectors. In April 2022, Illumina Inc ., announced the launch of a new regional Solution Center in São Paulo, Brazil, to address the increasing demand and interest for clinical genomics in Latin America. Such rapid expansion of genomic testing and gene expression analysis capabilities is anticipated to elevate the market value.
Latin America Gene Expression Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Process
Sample Collection
Purification
cDNA Synthesis & Conversion
PCR Analysis
Data Analysis & Interpretation
Market Breakup by Application
Clinical Diagnostics
Drug Discovery & Development
Research Activities
Other Applications
Market Breakup by Technique
RNA Expression
Promoter Analysis
Protein Expression & Posttranslational Modification Analysis
Market Breakup by Product
Consumables
Instruments
Services
Market Breakup by End User
Pharmaceutical and biotechnology companies
Diagnostic laboratories
Academic research centers
Market Breakup by Country
Brazil
Argentina
Mexico
Others
Leading Players in the Latin America Gene Expression Market
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- PerkinElmer
- Illumina, Inc.
- Oxford Gene Technology (OGT) Group
- Luminex Corporation
- QIAGEN
- Affymetrix
- Life Technologies
- Agilent Technologies
- Bio-Rad Laboratories
- GE Healthcare
FAQs
- What is the Latin America gene expression market forecast outlook for 2024-2032?
- What are the major factors aiding the Latin America gene expression market demand?
- What are the major Latin America gene expression market trends?
- What is the market segmentation based on the process?
- What are the applications of the market?
- What is the market breakup by technique?
- What is the market breakup by product?
- What are the major end users of the market?
- What is the market segmentation by countries?
- Who are the key players involved in the Latin America gene expression market?
Meta description
The Latin America gene expression market is poised for growth, driven by the expansion of the global market, which was valued at USD 13.3 billion in 2023 and is projected to grow at a CAGR of 10.42% during the forecast period of 2024-2032.
*Please Note:* The report will take 7 business days to complete, after order confirmation.
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Latin America Gene Expression Market Overview
- 3.1 Latin America Gene Expression Market Historical Value (2017-2023)
- 3.2 Latin America Gene Expression Market Forecast Value (2024-2032)
- 4 Latin America Gene Expression Market Landscape*
- 4.1 Latin America Gene Expression: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Latin America Gene Expression: Product Landscape
- 4.2.1 Analysis by Process
- 4.2.2 Analysis by Application
- 5 Latin America Gene Expression Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Latin America Gene Expression Market Segmentation (2017-2032)
- 6.1 Latin America Gene Expression Market (2017-2032) by Process
- 6.1.1 Market Overview
- 6.1.2 Sample Collection
- 6.1.3 Purification
- 6.1.4 cDNA Synthesis & Conversion
- 6.1.5 PCR Analysis
- 6.1.6 Data Analysis & Interpretation
- 6.2 Latin America Gene Expression Market (2017-2032) by Application
- 6.2.1 Market Overview
- 6.2.2 Clinical Diagnostics
- 6.2.3 Drug Discovery & Development
- 6.2.4 Research Activities
- 6.2.5 Other Applications
- 6.3 Latin America Gene Expression Market (2017-2032) by Technique
- 6.3.1 Market Overview
- 6.3.2 RNA Expression
- 6.3.3 Promoter Analysis
- 6.3.4 Protein Expression & Posttranslational Modification Analysis
- 6.4 Latin America Gene Expression Market (2017-2032) by Product
- 6.4.1 Market Overview
- 6.4.2 Consumables
- 6.4.3 Instruments
- 6.4.4 Services
- 6.5 Latin America Gene Expression Market (2017-2032) by End User
- 6.5.1 Market Overview
- 6.5.2 Pharmaceutical and Biotechnology Companies
- 6.5.3 Diagnostic Laboratories
- 6.5.4 Academic Research Centers
- 6.6 Latin America Gene Expression Market (2017-2032) by Country
- 6.6.1 Market Overview
- 6.6.2 Brazil
- 6.6.3 Argentina
- 6.6.4 Mexico
- 6.6.5 Others
- 7 Brazil Gene Expression Market (2017-2032)
- 7.1 Brazil Gene Expression Market (2017-2032) by Process
- 7.1.1 Market Overview
- 7.1.2 Sample Collection
- 7.1.3 Purification
- 7.1.4 cDNA Synthesis & Conversion
- 7.1.5 PCR Analysis
- 7.1.6 Data Analysis & Interpretation
- 7.2 Brazil Gene Expression Market (2017-2032) by Application
- 7.2.1 Market Overview
- 7.2.2 Clinical Diagnostics
- 7.2.3 Drug Discovery & Development
- 7.2.4 Research Activities
- 7.2.5 Other Applications
- 7.3 Brazil Gene Expression Market (2017-2032) by Technique
- 7.3.1 Market Overview
- 7.3.2 RNA Expression
- 7.3.3 Promoter Analysis
- 7.3.4 Protein Expression & Posttranslational Modification Analysis
- 7.4 Brazil Gene Expression Market (2017-2032) by Product
- 7.4.1 Market Overview
- 7.4.2 Consumables
- 7.4.3 Instruments
- 7.4.4 Services
- 7.5 Brazil Gene Expression Market (2017-2032) by End User
- 7.5.1 Market Overview
- 7.5.2 Pharmaceutical and Biotechnology Companies
- 7.5.3 Diagnostic laboratories
- 7.5.4 Academic Research Centers
- 8 Argentina Gene Expression Market (2017-2032)
- 8.1 Argentina Gene Expression Market (2017-2032) by Process
- 8.1.1 Market Overview
- 8.1.2 Sample Collection
- 8.1.3 Purification
- 8.1.4 cDNA Synthesis & Conversion
- 8.1.5 PCR Analysis
- 8.1.6 Data Analysis & Interpretation
- 8.2 Argentina Gene Expression Market (2017-2032) by Application
- 8.2.1 Market Overview
- 8.2.2 Clinical Diagnostics
- 8.2.3 Drug Discovery & Development
- 8.2.4 Research Activities
- 8.2.5 Other Applications
- 8.3 Argentina Gene Expression Market (2017-2032) by Technique
- 8.3.1 Market Overview
- 8.3.2 RNA Expression
- 8.3.3 Promoter Analysis
- 8.3.4 Protein Expression & Posttranslational Modification Analysis
- 8.4 Argentina Gene Expression Market (2017-2032) by Product
- 8.4.1 Market Overview
- 8.4.2 Consumables
- 8.4.3 Instruments
- 8.4.4 Services
- 8.5 Argentina Gene Expression Market (2017-2032) by End User
- 8.5.1 Market Overview
- 8.5.2 Pharmaceutical and Biotechnology Companies
- 8.5.3 Diagnostic Laboratories
- 8.5.4 Academic Research Centers
- 9 Mexico Gene Expression Market (2017-2032)
- 9.1 Mexico Gene Expression Market (2017-2032) by Process
- 9.1.1 Market Overview
- 9.1.2 Sample Collection
- 9.1.3 Purification
- 9.1.4 cDNA Synthesis & Conversion
- 9.1.5 PCR Analysis
- 9.1.6 Data Analysis & Interpretation
- 9.2 Mexico Gene Expression Market (2017-2032) by Application
- 9.2.1 Market Overview
- 9.2.2 Clinical Diagnostics
- 9.2.3 Drug Discovery & Development
- 9.2.4 Research Activities
- 9.2.5 Other Applications
- 9.3 Mexico Gene Expression Market (2017-2032) by Technique
- 9.3.1 Market Overview
- 9.3.2 RNA Expression
- 9.3.3 Promoter Analysis
- 9.3.4 Protein Expression & Posttranslational Modification Analysis
- 9.4 Mexico Gene Expression Market (2017-2032) by Product
- 9.4.1 Market Overview
- 9.4.2 Consumables
- 9.4.3 Instruments
- 9.4.4 Services
- 9.5 Mexico Gene Expression Market (2017-2032) by End User
- 9.5.1 Market Overview
- 9.5.2 Pharmaceutical and Biotechnology Companies
- 9.5.3 Diagnostic Laboratories
- 9.5.4 Academic Research Centers
- 10 Regulatory Framework
- 11 Funding and Investment Analysis
- 11.1 Analysis by Funding Instances
- 11.2 Analysis by Type of Funding
- 11.3 Analysis by Funding Amount
- 11.4 Analysis by Leading Players
- 11.5 Analysis by Leading Investors
- 11.6 Analysis by Geography
- 12 Partnership and Collaborations Analysis
- 12.1 Analysis by Partnership Instances
- 12.2 Analysis by Type of Partnership
- 12.3 Analysis by Leading Players
- 12.4 Analysis by Geography
- 13 Supplier Landscape
- 13.1 Market Share by Top 5 Companies
- 13.2 PerkinElmer
- 13.2.1 Financial Analysis
- 13.2.2 Product Portfolio
- 13.2.3 Demographic Reach and Achievements
- 13.2.4 Mergers and Acquisitions
- 13.2.5 Certifications
- 13.3 Illumina, Inc.
- 13.3.1 Financial Analysis
- 13.3.2 Product Portfolio
- 13.3.3 Demographic Reach and Achievements
- 13.3.4 Mergers and Acquisitions
- 13.3.5 Certifications
- 13.4 Oxford Gene Technology (OGT) Group
- 13.4.1 Financial Analysis
- 13.4.2 Product Portfolio
- 13.4.3 Demographic Reach and Achievements
- 13.4.4 Mergers and Acquisitions
- 13.4.5 Certifications
- 13.5 Luminex Corporation
- 13.5.1 Financial Analysis
- 13.5.2 Product Portfolio
- 13.5.3 Demographic Reach and Achievements
- 13.5.4 Mergers and Acquisitions
- 13.5.5 Certifications
- 13.6 QIAGEN
- 13.6.1 Financial Analysis
- 13.6.2 Product Portfolio
- 13.6.3 Demographic Reach and Achievements
- 13.6.4 Mergers and Acquisitions
- 13.6.5 Certifications
- 13.7 Affymetrix
- 13.7.1 Financial Analysis
- 13.7.2 Product Portfolio
- 13.7.3 Demographic Reach and Achievements
- 13.7.4 Mergers and Acquisitions
- 13.7.5 Certifications
- 13.8 Life Technologies
- 13.8.1 Financial Analysis
- 13.8.2 Product Portfolio
- 13.8.3 Demographic Reach and Achievements
- 13.8.4 Mergers and Acquisitions
- 13.8.5 Certifications
- 13.9 Agilent Technologies
- 13.9.1 Financial Analysis
- 13.9.2 Product Portfolio
- 13.9.3 Demographic Reach and Achievements
- 13.9.4 Mergers and Acquisitions
- 13.9.5 Certifications
- 13.10 Bio-Rad Laboratories
- 13.10.1 Financial Analysis
- 13.10.2 Product Portfolio
- 13.10.3 Demographic
- 13.10.4 Mergers and Acquisitions
- 13.10.5 Certifications
- 13.11 GE Healthcare
- 13.11.1 Financial Analysis
- 13.11.2 Product Portfolio
- 13.11.3 Demographic Reach and Achievements
- 13.11.4 Mergers and Acquisitions
- 13.11.5 Certifications
- 14 Latin America Gene Expression Market – Distribution Model (Additional Insight)
- 14.1 Overview
- 14.2 Potential Distributors
- 14.3 Key Parameters for Distribution Partner Assessment
- 15 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 16 Company Competitiveness Analysis (Additional Insight)
- 16.1 Very Small Companies
- 16.2 Small Companies
- 16.3 Mid-Sized Companies
- 16.4 Large Companies
- 16.5 Very Large Companies
- 17 Payment Methods (Additional Insight)
- 17.1 Government Funded
- 17.2 Private Insurance
- 17.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.